Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology
In this paper, we aim to capitalize on the lessons learnt from the impact of the COVID-19 pandemic on clinical trials and use them as a catalyst to launch a discussion over a framework of broader adaptations needed in the design and implementation of oncology clinical trials
COVID-19 pandemic; Oncology
Castelo-Branco L, Awada A, Pentheroudakis G, Perez-Gracia JL, Mateo J, Curigliano G, et al. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology. ESMO Open. 2021 Oct;6(5):100237.
Use this identifier for quote and/or link this documenthttps://hdl.handle.net/11351/7372
The following license files are associated with this item: